Benjamin J. Hindson - 01 Jun 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
01 Jun 2021
Net transactions value
-$7,217,004
Form type
4
Filing time
03 Jun 2021, 18:49:54 UTC
Previous filing
26 May 2021
Next filing
06 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $49,999 +41,666 +88% $1.20* 89,120 01 Jun 2021 Direct F1
transaction TXG Class A Common Stock Sale $1,422,406 -8,292 -9.3% $171.54 80,828 01 Jun 2021 Direct F1, F2
transaction TXG Class A Common Stock Sale $653,563 -3,792 -4.7% $172.35 77,036 01 Jun 2021 Direct F1, F3
transaction TXG Class A Common Stock Sale $602,346 -3,473 -4.5% $173.44 73,563 01 Jun 2021 Direct F1, F4
transaction TXG Class A Common Stock Sale $1,122,373 -6,433 -8.7% $174.47 67,130 01 Jun 2021 Direct F1, F5
transaction TXG Class A Common Stock Sale $2,338,596 -13,326 -20% $175.49 53,804 01 Jun 2021 Direct F1, F6
transaction TXG Class A Common Stock Sale $590,205 -3,350 -6.2% $176.18 50,454 01 Jun 2021 Direct F1, F7
transaction TXG Class A Common Stock Sale $160,188 -900 -1.8% $177.99 49,554 01 Jun 2021 Direct F1, F8
transaction TXG Class A Common Stock Sale $197,259 -1,100 -2.2% $179.33 48,454 01 Jun 2021 Direct F1, F9
transaction TXG Class A Common Stock Sale $180,068 -1,000 -2.1% $180.07 47,454 01 Jun 2021 Direct F1, F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -41,666 -27% $0.000000 112,748 01 Jun 2021 Class A Common Stock 41,666 $1.20 Direct F1, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $170.93 to $171.92. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $171.94 to $172.90. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $172.94 to $173.93. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $173.94 to $174.93. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $174.96 to $175.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 This transaction was executed in multiple trades at prices ranging from $175.99 to $176.89. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8 This transaction was executed in multiple trades at prices ranging from $177.62 to $178.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9 This transaction was executed in multiple trades at prices ranging from $178.69 to $179.655. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F10 This transaction was executed in multiple trades at prices ranging from $179.84 to $180.67. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F11 This option, originally for 200,000 shares, of which 87,252 shares have been exercised, vested as to one forty-eighth of the shares on October 1, 2017 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Remarks:

Chief Scientific Officer and President